CVE-2026-87239: financial-management
Affects financial-managementSource GCVE Database
Not known to be exploited · CVSS 7.2 High.
Data as of 30 Oct 2026, 20:25 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 41% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 15 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
Mavencom.oracle.hyperion/financial-managementpkg:maven/com.oracle.hyperion/financial-managementOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Oracle has released a Critical Security Patch Update in September 2026 that addresses this vulnerability. Customers should apply the official Oracle patches without delay to remediate this issue. Oracle strongly recommends remaining on actively-supported versions and promptly applying security patches. No alternative mitigations or workarounds are indicated in the advisory.
Description
A vulnerability in Oracle Hyperion Financial Management version 11.2.26.0.000 allows a high privileged attacker with network access via HTTP to compromise the system. The vulnerability has a CVSS 3.1 base score of 7.2, indicating high severity with impacts on confidentiality, integrity, and availability. Successful exploitation could lead to full takeover of the affected product.